Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease

  • 0Moscow Multidisciplinary Clinical Center "Kommunarka" of the Department of Health of the City of Moscow, State Budgetary Institution of Healthcare, Moscow, Russia.

|

|

Summary

This summary is machine-generated.

Microsatellite instability (MSI) in liquid biopsies can track colorectal cancer (CRC) treatment response. An increase in blood MSI (bMSI) correlated with disease progression during immunotherapy.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Microsatellite instability (MSI) is a key biomarker for predicting response to immune checkpoint inhibitors (ICIs) in colorectal cancer (CRC).
  • Liquid biopsies offer a non-invasive method to monitor tumor dynamics during therapy.